China Digest: Biotech startup Therorna and HR tech firm Yunsheng snag funds

Photo by RephiLe on Unsplash

China-based biotech firm Therorna Inc has secured over 280 million yuan (almost $42 million) in a Series A round. Separately, HR tech firm Shebao China has completed a Series C funding round at 270 million yuan ($40.4 million) alongside its rebranding as Yunsheng Group.

Biotech firm Therorna closes $42m in Series A round  

China-based biotech firm Therorna Inc has secured over 280 million yuan (almost $42 million) in a Series A round of financing to fund its development of circular RNA technology-based new vaccines and therapies.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter